Dissemination of vancomycin-resistant enterococci among haemodialysis patients in Athens, Greece

被引:15
作者
Kalocheretis, P
Baimakou, E
Zerbala, S
Papaparaskevas, J
Makriniotou, I
Tassios, PT
Iatrou, C
Kouskouni, E
Zerva, L
机构
[1] Univ Athens, Sch Med, Dept Microbiol, GR-11527 Athens, Greece
[2] Gen Hosp Nikaia, G Papadakis Ctr Nephrol, Piraeus, Greece
[3] Univ Athens, Arete Hosp, Lab Microbiol & Biochem, Athens, Greece
关键词
epidemiology; colonization; surveillance cultures;
D O I
10.1093/jac/dkh450
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: Vancomycin-resistant enterococci (VRE) may colonize haemodialysis patients, but their epidemiology in this population is not well defined. Within the few last years, VRE strains have emerged and are increasingly isolated in the nosocomial environment in Greece, but colonization of dialysis patients has never been evaluated before. This study sought to determine the epidemiology of VRE colonization within this high-risk population and define the risk factors. Materials and methods: During a 4 month period, rectal swabs or faecal specimens were collected from 334 consecutive outpatients, who were treated at four independent dialysis units located in the same area of Athens and referring patients to the same local hospital. The relatedness of isolates was defined by molecular typing, and demographic and clinical patient data were recorded. Results: Thirteen multiresistant Enterococcus faecium vanA strains were isolated corresponding to a colonization frequency of 3.9%. They were separated into seven clusters: type A (two strains), type B (six strains) and types C to G (one strain each). Type B strains originated from three units, while a single unit demonstrated four type B and two type A strains. Univariate statistical analysis revealed that prior hospitalization (P=0.001), prior administration of antimicrobials (P=0.026) and male gender (P=0.019) were associated with VRE colonization. Conclusions: In Greece, haemodialysis patients are colonized with VRE at a low frequency. The predominance of one clone and its isolation from several units strongly indicate interfacility transmission of strains, most probably within a health care environment shared by all patients.
引用
收藏
页码:1031 / 1034
页数:4
相关论文
共 18 条
[1]   Outpatient vancomycin use and vancomycin-resistant enterococcal colonization in maintenance dialysis patients [J].
Atta, MG ;
Eustace, JA ;
Song, XY ;
Perl, TM ;
Scheel, PJ .
KIDNEY INTERNATIONAL, 2001, 59 (02) :718-724
[2]   Vancomycin-resistant enterococci among chronic hemodialysis patients: A prospective study of acquisition [J].
D'Agata, EMC ;
Green, WK ;
Schulman, G ;
Li, HJ ;
Tang, YW ;
Schaffner, W .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (01) :23-29
[3]   Prevalence and molecular epidemiology of glycopeptide-resistant enterococci in Belgian renal dialysis units [J].
Descheemaeker, P ;
Ieven, M ;
Chapelle, S ;
Lammens, C ;
Hauchecorne, M ;
Wijdooghe, M ;
Vandamme, P ;
Goossens, H .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (01) :235-241
[4]   DETECTION OF GLYCOPEPTIDE RESISTANCE GENOTYPES AND IDENTIFICATION TO THE SPECIES LEVEL OF CLINICALLY RELEVANT ENTEROCOCCI BY PCR [J].
DUTKAMALEN, S ;
EVERS, S ;
COURVALIN, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (01) :24-27
[5]   Vancomycin-resistant enterococci in hemodialysis patients is related to intravenous vancomycin use [J].
Fishbane, S ;
Cunha, BA ;
Mittal, SK ;
Ruggian, J ;
Shea, K ;
Schoch, PE .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1999, 20 (07) :461-462
[6]   Insights into the epidemiology and control of infection with vancomycin-resistant enterococci [J].
Hayden, MK .
CLINICAL INFECTIOUS DISEASES, 2000, 31 (04) :1058-1065
[7]   Dissemination of clonally unrelated erythromycin- and glycopeptide-resistant Enterococcus faecium isolates in a tertiary Greek hospital [J].
Maniatis, AN ;
Pournaras, S ;
Kanellopoulou, M ;
Kontos, F ;
Dimitroulia, E ;
Papafrangas, E ;
Tsakris, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (12) :4571-4574
[8]   Drug therapy: Vancomycin-resistant enterococcal infections. [J].
Murray, BE .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (10) :710-721
[9]  
National Committee for Clinical Laboratory Standards, 2004, M100S14 NCCLS
[10]   Diversity among high-level aminoglycoside-resistant enterococci [J].
Papaparaskevas, J ;
Vatopoulos, A ;
Tassios, PT ;
Avlami, A ;
Legakis, NJ ;
Kalapothaki, V .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (03) :277-283